[{"id":"96c1a79b-dc4c-4532-bdcc-568aae7c4193","acronym":"","url":"https://clinicaltrials.gov/study/NCT05176691","created_at":"2022-01-04T13:53:37.587Z","updated_at":"2024-07-02T16:35:55.163Z","phase":"Phase 1","brief_title":"HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL","source_id_and_acronym":"NCT05176691","lead_sponsor":"Hutchmed","biomarkers":" CCL2","pipe":"","alterations":" ","tags":["CCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HMPL-760"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 02/15/2022","start_date":" 02/15/2022","primary_txt":" Primary completion: 11/16/2022","primary_completion_date":" 11/16/2022","study_txt":" Completion: 11/16/2022","study_completion_date":" 11/16/2022","last_update_posted":"2023-02-20"}]